Goldman Sachs Group Inc Iradimed Corp Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Iradimed Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 169,387 shares of IRMD stock, worth $9.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
169,387
Previous 169,387 -0.0%
Holding current value
$9.13 Million
Previous $8.89 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$51.44 - $62.67 $93,672 - $114,122
1,821 Added 1.09%
169,387 $8.89 Million
Q4 2024

Feb 11, 2025
BUY
$48.3 - $57.35 $512,801 - $608,884
10,617 Added 6.76%
167,566 $9.22 Million
Q3 2024

Nov 14, 2024
BUY
$43.23 - $50.29 $3.37 Million - $3.92 Million
77,956 Added 98.69%
156,949 $7.89 Million
Q2 2024

Aug 13, 2024
BUY
$40.36 - $44.7 $1.84 Million - $2.04 Million
45,712 Added 137.35%
78,993 $3.47 Million
Q1 2024

May 15, 2024
SELL
$41.17 - $47.29 $856,418 - $983,726
-20,802 Reduced 38.46%
33,281 $1.46 Million
Q4 2023

Feb 13, 2024
SELL
$37.31 - $47.47 $74,358 - $94,607
-1,993 Reduced 3.55%
54,083 $2.57 Million
Q3 2023

May 14, 2024
BUY
$43.28 - $50.3 $86,257 - $100,247
1,993 Added 3.69%
56,076 $2.49 Million
Q3 2023

Nov 14, 2023
BUY
$43.28 - $50.3 $394,237 - $458,182
9,109 Added 19.39%
56,076 $2.49 Million
Q2 2023

May 14, 2024
SELL
$38.88 - $50.61 $63,685 - $82,899
-1,638 Reduced 3.37%
46,967 $2.24 Million
Q2 2023

Aug 14, 2023
SELL
$38.88 - $50.61 $63,685 - $82,899
-1,638 Reduced 3.37%
46,967 $2.24 Million
Q1 2023

May 14, 2024
SELL
$28.48 - $42.14 $189,249 - $280,020
-6,645 Reduced 12.03%
48,605 $1.91 Million
Q1 2023

May 11, 2023
SELL
$28.48 - $42.14 $189,249 - $280,020
-6,645 Reduced 12.03%
48,605 $1.91 Million
Q4 2022

May 14, 2024
BUY
$26.9 - $30.58 $247,049 - $280,846
9,184 Added 19.94%
55,250 $1.56 Million
Q4 2022

Feb 13, 2023
BUY
$26.9 - $30.58 $247,049 - $280,846
9,184 Added 19.94%
55,250 $1.56 Million
Q3 2022

May 14, 2024
BUY
$29.42 - $42.25 $254,277 - $365,166
8,643 Added 23.1%
46,066 $1.39 Million
Q3 2022

Nov 10, 2022
BUY
$29.42 - $42.25 $254,277 - $365,166
8,643 Added 23.1%
46,066 $1.38 Million
Q2 2022

May 14, 2024
SELL
$30.15 - $45.79 $502,299 - $762,861
-16,660 Reduced 30.8%
37,423 $1.27 Million
Q2 2022

Aug 15, 2022
BUY
$30.15 - $45.79 $87,977 - $133,615
2,918 Added 8.46%
37,423 $1.27 Million
Q1 2022

May 16, 2022
BUY
$36.01 - $53.14 $729,742 - $1.08 Million
20,265 Added 142.31%
34,505 $1.55 Million
Q4 2021

Feb 14, 2022
SELL
$32.35 - $48.27 $7,472 - $11,150
-231 Reduced 1.6%
14,240 $659,000
Q3 2021

Nov 10, 2021
BUY
$29.5 - $37.21 $426,894 - $538,465
14,471 New
14,471 $486,000

Others Institutions Holding IRMD

# of Institutions
168
Shares Held
6.83M
Call Options Held
0
Put Options Held
0
View Full List

About IRADIMED CORP

IRMD Quotes by TradingView
  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $677M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email